Literature DB >> 28827907

Major Liver Resection for Large and Locally Advanced Hepatocellular Carcinoma.

Viniyendra Pamecha1, Shridhar Vasantrao Sasturkar1, Piyush Kumar Sinha1, Shyam Sundar Mahansaria1, Kishore G S Bharathy1, Senthil Kumar1, Archana Rastogi2.   

Abstract

Optimal management of large and locally advanced hepatocellular carcinoma (HCC) remains a clinical challenge especially in patients with chronic liver disease (CLD). We present our experience of major liver resection for large and locally advanced HCC. Prospectively collected data of patients with large and locally advanced HCC who underwent major liver resection between March 2011 and May 2015. The outcome measures of interest were the characteristics of tumor, surgical outcome, and overall as well as disease-free survival. Eighteen patients (14 male) with median age of 59 years (20 to 73 years) with good performance status underwent resection. Fifteen patients were in Child Pugh class A and three in class B. On contrast-enhanced computed tomography (CECT) scan, four patients had lobar/segmental portal vein involvement, two patients had bilobar disease, and one had biliary obstruction. Seven patients underwent extended resection (>5 segments), five right hepatectomy, two modified right hepatectomy, one modified right hepatectomy with wedge resection of segment six, two left hepatectomy, and one left lateral sectionectomy. On histopathology, 12 were solitary and six were multiple, the median tumor diameter was 9 cm (5-18 cm). All 18 patients had R0 resection. Eight patients had cirrhosis, six had fibrosis, and four had chronic hepatitis. Vascular invasion was noticed in 12 and out of these, six had large-vessel embolization. Morbidity according to Clavien-Dindo class was grades 1-11, grades 2-5, grade 3B-1, and grades 5-1. After a median follow-up of 32 months (6-54 months), the overall survival at 1 and 3 years was 83 and 54 %, respectively. The disease-free survival at 1 and 3 years was 75 and 54 % respectively. In carefully selected patients with large and locally advanced HCC, acceptable perioperative and medium term outcomes can be achieved with major liver resection.

Entities:  

Keywords:  Chronic liver disease; Cirrhosis; Hepatocellular carcinoma; Surgical resection

Year:  2016        PMID: 28827907      PMCID: PMC5549045          DOI: 10.1007/s12262-016-1545-3

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  34 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Liver resection for hepatocellular carcinoma in patients with cirrhosis.

Authors:  C-C Wu; S-B Cheng; W-M Ho; J-T Chen; T-J Liu; F-K P'eng
Journal:  Br J Surg       Date:  2005-03       Impact factor: 6.939

3.  Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications.

Authors:  Nazario Portolani; Arianna Coniglio; Sara Ghidoni; Mara Giovanelli; Anna Benetti; Guido Alberto Massimo Tiberio; Stefano Maria Giulini
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

4.  Comparison of staging systems to predict survival in hepatocellular carcinoma.

Authors:  Sonia Pascual; Pedro Zapater; José Such; Antonio García-Herola; Laura Sempere; Javier Irurzun; José María Palazón; Fernando Carnicer; Miguel Pérez-Mateo
Journal:  Liver Int       Date:  2006-08       Impact factor: 5.828

5.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

6.  Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection.

Authors:  Lian-Yue Yang; Feng Fang; Di-Peng Ou; Wei Wu; Zhi-Jun Zeng; Fan Wu
Journal:  Ann Surg       Date:  2009-01       Impact factor: 12.969

7.  Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.

Authors:  Takeaki Ishizawa; Kiyoshi Hasegawa; Taku Aoki; Michiro Takahashi; Yosuke Inoue; Keiji Sano; Hiroshi Imamura; Yasuhiko Sugawara; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Gastroenterology       Date:  2008-03-08       Impact factor: 22.682

Review 8.  Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.

Authors:  Jordi Bruix; Maria Reig; Morris Sherman
Journal:  Gastroenterology       Date:  2016-01-12       Impact factor: 22.682

9.  Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes?

Authors:  Prashant Bhangui; Marc Antoine Allard; Eric Vibert; Daniel Cherqui; Gilles Pelletier; Antonio Sa Cunha; Catherine Guettier; Jean-Charles Duclos Vallee; Faouzi Saliba; Henri Bismuth; Didier Samuel; Denis Castaing; René Adam
Journal:  Ann Surg       Date:  2016-07       Impact factor: 12.969

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  2 in total

1.  Left Hepatectomy Through Double Approach and Total Vascular Exclusion for Giant Left Lobe Hepatocarcinoma.

Authors:  Nicolae Bacalbasa; Irina Balescu; Simona Dima; Lucian Alecu; Irinel Popescu
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

2.  The High-Sensitivity C-Reactive Protein/Albumin Ratio Predicts Long-Term Oncologic Outcomes after Curative Resection for Hepatocellular Carcinoma.

Authors:  Tak Kyu Oh; Young-Rok Choi; Jai Young Cho; Yoo-Suk Yoon; Ho-Seong Han; In Sun Park; Jung-Hee Ryu
Journal:  J Clin Med       Date:  2018-06-07       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.